Dilapan Versus Laminaria (DvL)
This is a randomized, blinded clinical trial comparing overnight laminaria versus same-day Dilapan for cervical preparation for surgical abortions occurring between fourteen and eighteen weeks gestation. Comparisons will be made between procedure time, need for additional dilation, occurrence of complications, and patient and provider satisfaction.
Cervical preparation for surgical abortion, between fourteen and eighteen weeks gestation, with same-day Dilapan is non-inferior to cervical preparation with overnight laminaria within a five-minute difference.
Determine differences in procedure times
Examine complications, and need for additional dilation between early second-trimester surgical abortions performed after cervical preparation with same-day Dilapan versus those performed after cervical preparation with overnight laminaria
|Study Design:||Allocation: Randomized
Endpoint Classification: Bio-equivalence Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
|Official Title:||Same-day Dilapan Versus Overnight Laminaria for Cervical Preparation for Early Second-trimester Surgical Abortion|
- Procedure Time [ Time Frame: Day of procedure ] [ Designated as safety issue: No ]Procedure time to complete early second-trimester dilation and evacuation (D&E)
- Participants Who Experienced Complications or Need for Additional Dilation [ Time Frame: Day of procedure ] [ Designated as safety issue: No ]Any complications, or mechanical dilation required, for early second-trimester surgical abortions performed after cervical preparation with same-day Dilapan versus those performed after cervical preparation with overnight laminaria
|Study Start Date:||October 2008|
|Study Completion Date:||December 2009|
|Primary Completion Date:||December 2009 (Final data collection date for primary outcome measure)|
Active Comparator: laminaria
laminaria placed for cervical dilation; usual standard of care in study clinic
place device in cervix for dilation
Place in cervix for dilation.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00775983
|United States, California|
|San Francisco General Hospital|
|San Francisco, California, United States, 94110|